John R Doubman

CIK 1755311 · View on SEC EDGAR ↗

Insider

First SEC filing: Oct. 10, 2018 · Latest: June 26, 2025

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 14 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 25, 2025 BOOM A 14,459 14,459 Direct Acquired (price as of 2026-08-20)
Sept. 30, 2019 CBT A 53 $45.32 $2,402 4,026 Direct +1.33% Acquired 86.8% (price as of 2026-08-20)
Sept. 13, 2019 CBT A 29 $47.23 $1,370 3,973 Direct +0.74% Acquired 79.2% (price as of 2026-08-20)
June 14, 2019 CBT A 30 $45.47 $1,364 3,944 Direct +0.77% Acquired 86.2% (price as of 2026-08-20)
March 14, 2019 CBT I 294 $12.30 $3,616 7,780 Indirect +3.93% Acquired 588.3% (price as of 2026-08-20)
March 13, 2019 CBT I 6,248 7,487 Indirect +504.28% Acquired (price as of 2026-08-20)
March 8, 2019 CBT A 29 $43.72 $1,268 3,914 Direct +0.75% Acquired 93.6% (price as of 2026-08-20)
Dec. 31, 2018 CBT A 848 $42.94 $36,413 3,884 Direct +27.93% Acquired 97.1% (price as of 2026-08-20)
Dec. 14, 2018 CBT A 23 $43.77 $1,007 3,036 Direct +0.76% Acquired 93.4% (price as of 2026-08-20)
Nov. 20, 2018 CBT F 1,401 $48.00 $67,248 20,427 Direct -6.42% Disposed 76.4% (price as of 2026-08-20)
Nov. 19, 2018 CBT A 5,599 21,828 Direct +34.50% Acquired (price as of 2026-08-20)
Nov. 12, 2018 CBT F 970 $48.45 $46,996 16,229 Direct -5.64% Disposed 74.7% (price as of 2026-08-20)
Nov. 9, 2018 CBT A 18,356 18,356 Direct Acquired (price as of 2026-08-20)
Nov. 9, 2018 CBT A 3,600 17,199 Direct +26.47% Acquired (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Sept. 30, 2019 CBT Phantom Stock Units Common Stock (53) 53 Acquired
Sept. 13, 2019 CBT Phantom Stock Common Stock (29) 29 Acquired
June 14, 2019 CBT Phantom Stock Common Stock (30) 30 Acquired
March 8, 2019 CBT Phantom Stock Common Stock (29) 29 Acquired
Dec. 31, 2018 CBT Phantom Stock Units Common Stock (848) 848 Acquired
Dec. 14, 2018 CBT Phantom Stock Common Stock (23) 23 Acquired
Nov. 9, 2018 CBT Employee Stock Option (Right to Buy) Common Stock (18,356) $50.00 Nov. 8, 2028 18,356 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 8 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Oct. 10, 2018 CBT Common Stock Direct
Oct. 10, 2018 CBT Common Stock 825 Indirect
Oct. 10, 2018 CBT Employee Stock Option (Right to Buy)→ Common Stock (4,017) 4,017 Direct
Oct. 10, 2018 CBT Employee Stock Option (Right to Buy)→ Common Stock (2,306) 2,306 Direct
Oct. 10, 2018 CBT Employee Stock Option (Right to Buy)→ Common Stock (2,834) 2,834 Direct
Oct. 10, 2018 CBT Employee Stock Option (Right to Buy)→ Common Stock (13,747) 13,747 Direct
Oct. 10, 2018 CBT Employee Stock Option (Right to Buy)→ Common Stock (12,639) 12,639 Direct
Oct. 10, 2018 CBT Phantom Stock→ Common Stock (3,096) 3,096 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CBT

President and President, Performance Additives
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2019 $395,000 $176,224 $1,102 $57,429 $1,342,913

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.